Literature DB >> 237497

Inactivation of African horse-sickness virus by betapropiolactone and by pH.

J Parker.   

Abstract

The inactivation of several types of African horse sickness virus (AHSV) by pH and by betapropiolactone (BPL) was studied. At 19 degrees - 22 degrees C the virus was stable between pH 6.0 and 10.4, whether suspended in mouse brain or in serumfree buffer. Below pH 5.6 and above pH 10.9, more than 99 per cent of infectivity was inactivated within 15 minutes. The addition of 50 per cent serum did not influence pH stability. Disinfection in the presence of citric acid and caustic soda is briefly discussed. Inactivation by BPL was complete within 30 minutes at 37 degrees C, yet incomplete after 15 hours at 4 degrees C. Types 3 and 9 virus grown in suckling mouse brain and types 1, 3 and 9 produced in pig kidney cells were equally susceptible to 0.1 per cent BPL, more than 99.9 per cent being inactivated. The effectiveness of BPL was reduced at least 10-fold by the addition of 50 per cent serum. No infective virus was detected following incubation of either tissue culture virus with 0.2 per cent BPL or of mouse brain virus with 0.3 per cent BPL. Virus suspensions exposed to 0.3 per cent BPL required buffering with Tris of at least 0.05 molar strength in order to maintain the pH within an acceptable range. Inactivated antigens prepared with 0.4 per cent or lower concentrations of BPL were immunogenic in guinea pigs.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 237497     DOI: 10.1007/bf01347977

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  17 in total

1.  Investigations of the use of beta-propiolactone in virus inactivation.

Authors:  G A LOGRIPPO
Journal:  Ann N Y Acad Sci       Date:  1960-01-13       Impact factor: 5.691

2.  Antigenicity of combined beta-propiolactone and ultraviolet inactivated virus vaccines.

Authors:  G A LOGRIPPO
Journal:  J Immunol       Date:  1958-03       Impact factor: 5.422

3.  Antigenicity of beta-propiolactone-inactivated virus vaccines.

Authors:  G A LOGRIPPO; F W HARTMAN
Journal:  J Immunol       Date:  1955-08       Impact factor: 5.422

4.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.

Authors:  I MACPHERSON; M STOKER
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

5.  The action of heat, chemicals and disinfectants on swine vesicular disease virus.

Authors:  K A Herniman; P M Medhurst; J N Wilson; R F Sellers
Journal:  Vet Rec       Date:  1973-12-15       Impact factor: 2.695

6.  African horse sickness virus antibodies in Cyprus--1971-72.

Authors:  J Parker
Journal:  Vet Rec       Date:  1974-04-20       Impact factor: 2.695

7.  Use of a new buffer in the culture of animal cells.

Authors:  J D Williamson; P Cox
Journal:  J Gen Virol       Date:  1968-03       Impact factor: 3.891

8.  Inactivated African horse sickness virus cell culture vaccine.

Authors:  H Mirchamsy; H Taslimi
Journal:  Immunology       Date:  1968-01       Impact factor: 7.397

9.  Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin.

Authors:  T J Wiktor; F Sokol; E Kuwert; H Koprowski
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

10.  Preparation of noninfectious arbovirus antigens.

Authors:  O M Brand; W P Allen
Journal:  Appl Microbiol       Date:  1970-09
View more
  1 in total

1.  The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods.

Authors:  Hyunil Kim; Hye Kwon Kim; Jung Ho Jung; Yoo Jung Choi; Jiho Kim; Chang Gyu Um; Su Bin Hyun; Sungho Shin; Byeongchun Lee; Goo Jang; Bo Kyu Kang; Hyoung Joon Moon; Dae Sub Song
Journal:  Virol J       Date:  2011-06-27       Impact factor: 4.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.